MEX-NM-301

· Lupin Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEX-NM-301, covering 2025-07-25 to 2025-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study. [NA]